MNOV — MEDICINOVA INC

Nasdaq · Health Care · Pharmaceuticals · CIK 1226616 ·
Last close
$1.37
Market Cap
$67.43M
52W High
$1.57
52W Low
$1.29
ADV30
21,124
Next earnings
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 186,984 16,883 -2,835,806 -2,586,258 42,704,854 27,329,415 3,297,620
Dec 2025 151,739 4,754 -3,092,402 -2,802,279 45,603,109 30,806,477 4,016,428
Sep 2025 123,319 8,047 -3,380,998 -3,050,373 47,578,388 32,562,612 3,613,632
Jun 2025 134,599 18,250 -3,607,092 -3,281,185 49,823,875 34,259,637 2,967,006

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-9,810,061
Investing CF
$-2,705
Financing CF
CapEx
$-6
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.25
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-438,749,199
Inventory
Receivables
$134,599
ST Investments
EBIT TTM
$-13,283,002
Pretax Income TTM
$-11,991,963
Interest Exp TTM
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$596,641
EBITDA
$-12,897,116
Free Cash Flow
$-5,960,130
Enterprise Value
$41,745,528
Total Cash
$27,329,416
Total Debt
$165,198
Shares Out
49,221,246
Trailing EPS
$-0.23
Book Value
$0.80
ROE
-26.2%
ROA
-17.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 409,657 -13,283,002 -11,997,957 45,603,109 4,016,428 -9,810,061
Dec 2024 0 -12,675,331 -11,049,549 55,875,926 3,372,375 -10,642,964
Dec 2023 1,000,000 -9,900,265 -8,571,516 66,269,977 3,891,553 -7,431,038
Dec 2022 0 -14,628,649 -14,069,083 74,154,905 3,912,870 -12,911,563

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.43

Peers — same industry

TickerNameMarket CapLastDaily %
RFL Rafael Holdings, Inc. $67.62M $1.32
IMMP IMMUTEP Ltd $66.86M $0.45
FLNA FILANA THERAPEUTICS, INC. $68.11M $1.41
PMVP PMV Pharmaceuticals, Inc. $65.60M $1.23
LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. $69.96M $5.65

News headlines (Yahoo Finance, 1h cache)

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
2026-05-26 23:00 · Yahoo
We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth
2026-05-16 12:28 · Yahoo
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
2026-04-27 23:00 · Yahoo
Super Micro downgraded, MongoDB upgraded: Wall Street's top analyst calls
2026-03-23 13:44 · Yahoo
MediciNova to Participate at the 38th Annual ROTH Conference
2026-03-16 11:00 · Yahoo
MediciNova: Q4 Earnings Snapshot
2026-02-20 11:40 · Yahoo
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmenta
2026-02-19 08:30 · Yahoo
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
2026-01-29 23:00 · Yahoo
ATA Creativity Global Among 3 Promising Penny Stocks
2026-01-20 12:05 · Yahoo
2026 New Year’s Greetings from the CEO
2026-01-06 14:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.